Erlanger Cancer Center at Erlanger Hospital - Baroness — Chattanooga, Tennessee

Erlanger Cancer Center at Erlanger Hospital - Baroness is a clinical research site located in Chattanooga, Tennessee, United States 37403.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Erlanger Cancer Center at Erlanger Hospital - Baroness has participated in 7 clinical trials.

Therapeutic areas: Colorectal Cancer, Pancreatic Cancer, Breast Cancer.

Sponsors: Eastern Cooperative Oncology Group, Vanderbilt-Ingram Cancer Center, ETOP IBCSG Partners Foundation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Erlanger Cancer Center at Erlanger Hospital - Baroness?

Erlanger Cancer Center at Erlanger Hospital - Baroness has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Erlanger Cancer Center at Erlanger Hospital - Baroness conducted?

Erlanger Cancer Center at Erlanger Hospital - Baroness has 7 clinical trials on record. Their work covers Colorectal Cancer, Pancreatic Cancer, Breast Cancer.

Is Erlanger Cancer Center at Erlanger Hospital - Baroness accredited by Crixeo Clinical Trials?

Erlanger Cancer Center at Erlanger Hospital - Baroness has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Erlanger Cancer Center at Erlanger Hospital - Baroness?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.